Search results for "Breast cancer"
Use of hormonal contraceptive pills may be associated with increased risk of breast cancer
While the 20% increased risk among women using contemporary formulations of oral contraceptives is similar to that initially reported among users of older formulations, an editorial noted, the finding that breast cancer risk continues to be elevated for five years or more should be regarded as preliminary because the increase in risk would not have remained significant after adjustment.
https://immattersacp.org/weekly/archives/2017/12/12/4.htm
12 Dec 2017
ACS/ASCO issue guideline on caring for breast cancer survivors; study looks at association between screen-detected DCIS, invasive breast cancer
The 5 areas covered by the guideline are surveillance for breast cancer recurrence, screening for second primary cancer, assessment and management of physical and psychosocial long-term and late effects of breast cancer and treatment, health promotion, and care coordination and practice implications.
https://immattersacp.org/weekly/archives/2015/12/15/4.htm
15 Dec 2015
OTC birth control pill, naloxone gain approval
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/09/otc-birth-control-pill-naloxone-gain-approval.htm
1 Sep 2023
Recurrence of estrogen-receptor-positive early-stage breast cancer after endocrine therapy associated with TN status at diagnosis
Patients with stage T1 disease had a 13% risk of distant recurrence with no nodal involvement, 20% risk with involvement of one to three nodes, and 34% risk with involvement of four to nine nodes.
https://immattersacp.org/weekly/archives/2017/11/14/2.htm
14 Nov 2017
DynaMed Plus Quiz: Breast cancer screening
Test yourself with this quiz from DynaMed Plus.
https://immattersacp.org/archives/2017/07/dynamed-plus-quiz-breast-cancer-screening.htm
1 Jul 2017
Menopausal hormone therapy linked to breast cancer risk
An individual patient-level meta-analysis found that risk for breast cancer increased steadily with duration of use for all types of menopausal hormone therapy except vaginal estrogen and that risk was higher with estrogen-progestogen than estrogen-only formulations.
https://immattersacp.org/weekly/archives/2019/09/10/1.htm
10 Sep 2019
What's next for breast cancer screening?
Mammography screening guidelines by the U.S. Preventive Services Task Force set off a firestorm of controversy. But now that the flames have subsided, doctors need to know what to tell their patients.
https://immattersacp.org/archives/2010/02/editors.htm
1 Feb 2010
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2020/02/latest-updates-on-acps-priorities-initiatives.htm
1 Feb 2020
Calmer talk needed about mammography
Controversy about implementing new mammography guidelines shouldn't cloud talks between doctors and the women they counsel. Clarify what the guidelines really say, and share the decision-making with patients, experts counsel.
https://immattersacp.org/archives/2010/02/breast.htm
1 Feb 2010
New guidance issued on breast cancer screening, hormone therapy
Among other recommendations, screening mammography should be offered to women at average risk of breast cancer starting at age 40 years, and a shared decision-making process should be used to decide about the age to begin mammography screening.
https://immattersacp.org/weekly/archives/2017/06/27/1.htm
27 Jun 2017